Skip to main content

Table 7 Risk factors of pulmonary hypertension, anemia and serositis in SLE flare

From: Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis

 

Pulmonary hypertension

Anemia associated with SLE

Serositis

OR

95%CI

OR

95%CI

OR

95%CI

Age

1.007

(0.963,1.053)

0.978

(0.946,1.012)

0.979

(0.942,1.018)

Gender

0.000

/

0.480

(0.094,2.446)

0.177

(0.019,1.160)

Disease duration

1.000

(0.993,1.008)

1.002

(0.995,1.008)

1.003

(0.996,1.010)

SLEDAI-2 K

1.024

(0.942,1.113)

1.134

(1.059,1.214)e

1.156

(1.070,1.248)g

Glucocorticoid amount

0.577

(0.105,3.185)

0.784

(0.426,1.442)

0.889

(0.503,1.609)

Hydroxychloroquine

0.704

(0.217,2.290)

1.722

(0.602,4.963)

2.085

(0.637,6.821)

Immunosuppressive therapy

0.883

(0.299,2.606)

0.973

(0.423,2.236)

0.742

(0.294,1.874)

Regular maintenance treatment

0.158

(0.043,0.577)a

0.319

(0.141,0.720)f

0.362

(0.145,0.908)h

Maintenance therapy < 1 years

4.000

(1.232,12.989) b

0.687

(0.205,2.299)

5.764

(1.642,20.241) i

Maintenance therapy < 2 years

3.208

(1.129,9.115) c

0.799

(0.288,2.216)

2.283

(0.759,6.684)

Maintenance therapy < 3 years

2.986

(1.087,8.202)d

0.734

(0.266,2.022)

1.745

(0.584,5.215)

Maintenance therapy < 4 years

2.252

(0.627,8.089)

0.776

(0.254,2.374)

1.335

(0.403,4.420)

  1. a:P = 0.005; b:P = 0.021; c: P = 0.029; d: P = 0.034; e: P < 0.001; f: P = 0.006; g: P < 0.001; h: P = 0.030; i:P = 0.006; SLEDAI-2 K Systemic lupus erythematosus disease activity index-2000